Skip to main content
. 2024 Dec 18;24:1551. doi: 10.1186/s12885-024-13309-z

Fig. 1.

Fig. 1

Overall survival (OS) and progression free survival (PFS) of patients in each HRA group. A OS of patients without HRA, those with 1 HRA and those with ≥ 2 HRA. B PFS of patients without HRA, those with 1 HRA and those with ≥ 2 HRA